Guizhou Xinbang Pharmaceutical Co (SZSE:002390) EPS (Basic) : ¥0.05 (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Guizhou Xinbang Pharmaceutical Co EPS (Basic)?

Guizhou Xinbang Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was ¥-0.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was ¥0.05.

Guizhou Xinbang Pharmaceutical Co's EPS (Diluted) for the three months ended in Dec. 2024 was ¥-0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ¥0.05.

Guizhou Xinbang Pharmaceutical Co's EPS without NRI for the three months ended in Dec. 2024 was ¥-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 0.08.

During the past 12 months, Guizhou Xinbang Pharmaceutical Co's average EPS without NRIGrowth Rate was -35.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -17.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was -6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Guizhou Xinbang Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 39.40% per year. The lowest was -17.50% per year. And the median was 2.30% per year.

Guizhou Xinbang Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Guizhou Xinbang Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Xinbang Pharmaceutical Co EPS (Basic) Chart

Guizhou Xinbang Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.11

0.15

0.12

0.15

0.05

Guizhou Xinbang Pharmaceutical Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															0.02	0.03	0.03	0.03	-0.04

Guizhou Xinbang Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Guizhou Xinbang Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(101.382	-	0)	/	2027.632
	=	0.05

Guizhou Xinbang Pharmaceutical Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-75.208	-	0)	/	2395.657
	=	-0.03

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.05

Guizhou Xinbang Pharmaceutical Co (SZSE:002390) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Guizhou Xinbang Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Guizhou Xinbang Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Guizhou Xinbang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Xinbang Pharmaceutical Co Ltd (SZSE:002390) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

6th Floor, Kekai 1st Court, Intersection of Aerospace Avenue and Xintian Avenue, Wudang District, Guiyang, CHN

Website

http://www.xinbang.com

Guizhou Xinbang Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company is engaged in providing medical services and pharmaceutical distribution. The scope of business also covers the cultivation of Chinese herbal medicines, production of Chinese herbal medicines and Chinese patent medicines, research and development, production and sales of biological drugs, and other fields.

Executives

An Ji	Director
Gao Wen Lin	Executives
Lu Ya Fang	Executives
Xu Qi	Directors, executives
An Huai Lve	Director
Ma Cheng	Director
Zhang Jie Qing	Directors, executives
Kong Ling Zhong	Directors, executives
Liu Xiao Yang	Executives
Xiao Ya Yun	Executives
Yang Pei	Executives
Zhang Guan Fu	Director
Chen Chuan	Directors, executives
He Wen Jun	Supervisors
Lv Yu Tao	Director

Guizhou Xinbang Pharmaceutical Co Headlines

No Headlines